MENU
EVO
AS OF
Feb 5, 03:03 PM (EDT)
Price
$3.54
Change
-$0.18 (-4.84%)
Capitalization
1.36B
55 days until earnings call
Intraday BUY SELL Signals
+Compare
EVO
Stock ticker: NASDAQ
AS OF
Feb 5, 03:03 PM (EDT)
Price
$3.54
Change
-$0.18 (-4.84%)
Capitalization
1.36B

EVO Evotec SE Forecast, Technical & Fundamental Analysis

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

EVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EVO with price predictions
Feb 04, 2026

EVO saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for EVO moved out of overbought territory on February 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 59 similar instances where the indicator exited the overbought zone. In of the 59 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for EVO moved out of overbought territory on January 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for EVO turned negative on February 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EVO broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on EVO as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EVO moved above its 50-day moving average on January 06, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EVO crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EVO advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 152 cases where EVO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.398) is normal, around the industry mean (29.785). P/E Ratio (0.000) is within average values for comparable stocks, (74.299). EVO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.062). EVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (1.478) is also within normal values, averaging (111.885).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
EVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVO is expected to report earnings to fall 155.86% to 2 cents per share on April 01

Evotec SE EVO Stock Earnings Reports
Q4'25
Est.
$0.03
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.09
Q4'24
Missed
by $0.09
The last earnings report on November 05 showed earnings per share of -4 cents, beating the estimate of -7 cents. With 40.15K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FQUAX20.030.50
+2.56%
AMG River Road Large Cap Value Select N
MGLCX16.710.20
+1.21%
MFS Global Real Estate C
COIIX18.25-0.05
-0.27%
Calvert International Opportunities I
PIOKX46.40-0.48
-1.02%
Victory Pioneer R6
BGAIX50.65-0.75
-1.46%
Baron Global Opportunity Institutional

EVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EVO has been loosely correlated with SNDL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if EVO jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVO
1D Price
Change %
EVO100%
-1.85%
SNDL - EVO
42%
Loosely correlated
-1.89%
PRGO - EVO
27%
Poorly correlated
+4.03%
ACET - EVO
26%
Poorly correlated
-3.51%
HCM - EVO
25%
Poorly correlated
+2.71%
OGI - EVO
25%
Poorly correlated
-1.27%
More

Groups containing EVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVO
1D Price
Change %
EVO100%
-1.85%
Pharmaceuticals: Generic
industry (214 stocks)
18%
Poorly correlated
-0.09%